Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis a vaccine, inactivated + measles, mumps, rubella and varicella virus vaccine, live
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular (for Hepatitis A Component), Subcutaneous (for Mmrv Component)
01
Overview
This product is a **combination vaccine** consisting of an inactivated hepatitis A vaccine and a live attenuated measles, mumps, rubella, and varicella (MMRV) virus vaccine. The hepatitis A component works by stimulating production of protective antibodies against hepatitis A virus without containing live virus, while the MMRV component contains weakened (attenuated) viruses of measles, mumps, rubella, and varicella to elicit long-term immunity against these pathogens. Such vaccines are designed to reduce the number of injections through co-administration. No uniquely branded product combining hepatitis A (inactivated) and MMRV in one formulation is currently FDA-approved or widely marketed; these vaccines are generally administered separately, although co-administration in the same session is a practice in pediatric immunization schedules[2][4][7][8]. The product, as described, would be intended for **prevention of hepatitis A, measles, mumps, rubella, and varicella infections**, particularly in young children.
- Brand names
- ProQuad
- Other names
- MMRV vaccineMMRVmeasles, mumps, rubella and varicella virus vaccine livehepatitis A vaccine, inactivated + MMRVHAV + MMRV
Beyond the preview
Go deeper on hepatitis a vaccine, inactivated + measles, mumps, rubella and varicella virus vaccine, live.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis a vaccine, inactivated + measles, mumps, rubella and varicella virus vaccine, live.